Peripherally Inserted Central Catheter Insertion Site and Complication Rate in Neonates
1 other identifier
interventional
320
1 country
1
Brief Summary
This study examines whether there is an association between the PICC insertion site and the complications necessitating PICC removal in neonates admitted to neonatal intensive care unit.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2018
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 14, 2018
CompletedFirst Posted
Study publicly available on registry
March 23, 2018
CompletedStudy Start
First participant enrolled
October 19, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedMay 19, 2023
May 1, 2023
7.2 years
March 14, 2018
May 17, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Primary outcome is the presence of any complication which necessitates PICC removal
Line infiltration will be defined as extravasation of fluid into soft tissue around the region of the catheter tip. Line occlusion will be defined as inability to infuse fluid, resulting in removal of line. Phlebitis will be defined as presence of a linear red streak developing along the superficial veins from the catheter insertion site. Line associated thrombosis will be defined as ultrasound proven evidence of an occlusive thrombus in an anatomic location in proximity to the site of PICC.CLABSI will be defined according to Center for Disease Control definitions 26, that is, (1) confirmed primary bloodstream infection with (2) one of following clinical signs of infection (fever, hypothermia, apnea, or bradycardia) and (3) presence of central catheter at the time of or within 48 hours before the onset of the infection. Major life-threatening complications will include pleural effusion, pericardial effusion and cardiac tamponade, retroperitoneal extravasation.
Through study completion, within 4 weeks
Secondary Outcomes (1)
Secondary outcome will be time to complication post insertion
Through study completion, within 4 weeks
Study Arms (2)
Upper Extremity Insertion
EXPERIMENTALPeripherally Inserted Central Venous Cather (PICC) inserted in upper extremity
Lower Extremity Insertion
EXPERIMENTALPeripherally Inserted Central Venous Cather (PICC) inserted in lower extremity
Interventions
Location of the PICC insertion will be randomized and compared
Eligibility Criteria
You may qualify if:
- Neonates of all gestational ages admitted to Foothills Medical Centre and Alberta Children's Hospital Neonatal Intensive Care Unit (NICU)
- Peripherally inserted central venous catheter (PICC) line insertion planned as part of NICU care
- Venous access available in both upper(above umbilicus) and lower body
You may not qualify if:
- Local infection at potential site of insertion
- Hemangioma, lymphangioma or malformations in the region of insertion
- Major chromosomal anomalies
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Foothills Medical Centre
Calgary, Alberta, T2N2T9, Canada
Study Officials
- PRINCIPAL INVESTIGATOR
Amuchou Soraisham, MD
University of Calgary
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Neonatologist
Study Record Dates
First Submitted
March 14, 2018
First Posted
March 23, 2018
Study Start
October 19, 2018
Primary Completion
December 31, 2025
Study Completion
December 31, 2025
Last Updated
May 19, 2023
Record last verified: 2023-05